XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Stockholders' Investment - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares)     118,664       118,664  
Beginning balance $ 1,784,387 $ 1,734,725 $ 1,722,051 $ 1,510,441 $ 1,429,994 $ 1,418,697 $ 1,722,051 $ 1,418,697
Net income 162,987 152,471 135,302 97,229 126,251 92,904 $ 450,760 316,384
Foreign currency adjustments (2,772) 28,085 10,435 29,494 (1,313) (19,490)    
Dividends declared (75,456) (75,702) (74,418) (75,896) (74,006) (74,065)    
Stock issued for employee benefit plans 81,657 5,458 (33,021) 56,794 9,943 (10,725)    
Stock-based compensation expense 18,746 20,882 23,146 22,004 19,572 22,673    
Repurchase of common stock $ (112,508) (81,532) (48,770)          
Ending balance (in shares) 118,421           118,421  
Ending balance $ 1,857,041 $ 1,784,387 $ 1,734,725 $ 1,640,066 $ 1,510,441 $ 1,429,994 $ 1,857,041 $ 1,640,066
Dividends declared, per share (in dollars per share) $ 0.62 $ 0.62 $ 0.62 $ 0.62 $ 0.61 $ 0.61    
Common Stock                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares) 118,317 118,958 118,664 117,262 117,000 116,768 118,664 116,768
Beginning balance $ 11,832 $ 11,896 $ 11,866 $ 11,726 $ 11,700 $ 11,677 $ 11,866 $ 11,677
Stock issued for employee benefit plans (in shares) 1,062 229 779 821 262 232    
Stock issued for employee benefit plans $ 106 $ 23 $ 78 $ 82 $ 26 $ 23    
Stock-based compensation expense (in shares) 0 0 0 0 0 0    
Stock-based compensation expense $ 0 $ 0 $ 0 $ 0 $ 0 $ 0    
Repurchase of common stock (in shares) (958) (870) (485)          
Repurchase of common stock $ (96) $ (87) $ (48)          
Ending balance (in shares) 118,421 118,317 118,958 118,083 117,262 117,000 118,421 118,083
Ending balance $ 11,842 $ 11,832 $ 11,896 $ 11,808 $ 11,726 $ 11,700 $ 11,842 $ 11,808
Additional Paid-in Capital                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance 724,076 715,021 775,054 756,135 746,998 754,093 775,054 754,093
Stock issued for employee benefit plans (816) (11,827) (83,179) (6,654) (10,435) (29,768)    
Stock-based compensation expense 18,746 20,882 23,146 22,004 19,572 22,673    
Ending balance 742,006 724,076 715,021 771,485 756,135 746,998 742,006 771,485
Retained Earnings                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance 5,923,990 5,847,221 5,786,337 5,691,874 5,639,629 5,620,790 5,786,337 5,620,790
Net income 162,987 152,471 135,302 97,229 126,251 92,904    
Dividends declared (75,456) (75,702) (74,418) (75,896) (74,006) (74,065)    
Ending balance 6,011,521 5,923,990 5,847,221 5,713,207 5,691,874 5,639,629 6,011,521 5,713,207
Accumulated Other Comprehensive Loss                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (71,882) (99,967) (110,402) (101,749) (100,436) (80,946) (110,402) (80,946)
Foreign currency adjustments (2,772) 28,085 10,435 29,494 (1,313) (19,490)    
Ending balance (74,654) (71,882) (99,967) (72,255) (101,749) (100,436) (74,654) (72,255)
Treasury Stock                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (4,803,629) (4,739,446) (4,740,804) (4,847,545) (4,867,897) (4,886,917) (4,740,804) (4,886,917)
Stock issued for employee benefit plans 82,367 17,262 50,080 63,366 20,352 19,020    
Stock-based compensation expense 0 0 0 0 0 0    
Repurchase of common stock (112,412) (81,445) (48,722)          
Ending balance $ (4,833,674) $ (4,803,629) $ (4,739,446) $ (4,784,179) $ (4,847,545) $ (4,867,897) $ (4,833,674) $ (4,784,179)